Andersen A - Search Results

1

Acute changes in plasma glucose increases left ventricular systolic function in insulin-treated patients with type 2 diabetes and controls.

Andersen A, Jørgensen PG, Bagger JI, Baldassarre MPA, Christensen MB, Pedersen-Bjergaard U, Lindhardt TB, Gislason G, Knop FK, Vilsbøll T. Andersen A, et al. Diabetes Obes Metab. 2022 Jun;24(6):1123-1131. doi: 10.1111/dom.14682. Epub 2022 Mar 22. Diabetes Obes Metab. 2022. PMID: 35238140 Free PMC article. Clinical Trial.

2

Optimum bolus wizard settings in insulin pumps in children with Type 1 diabetes.

Andersen AJ, Ostenfeld A, Pipper CB, Olsen BS, Hertz AM, Jørgensen LK, Høgsmose J, Svensson J. Andersen AJ, et al. Diabet Med. 2016 Oct;33(10):1360-5. doi: 10.1111/dme.13064. Epub 2016 Feb 5. Diabet Med. 2016. PMID: 26773826

3

Cardiovascular biomarkers in clinical studies of type 2 diabetes.

Baldassarre MPA, Andersen A, Consoli A, Knop FK, Vilsbøll T. Baldassarre MPA, et al. Among authors: andersen a. Diabetes Obes Metab. 2018 Jun;20(6):1350-1360. doi: 10.1111/dom.13247. Epub 2018 Mar 5. Diabetes Obes Metab. 2018. PMID: 29419909 Review.

4

Glucagon-like peptide 1 in health and disease.

Andersen A, Lund A, Knop FK, Vilsbøll T. Andersen A, et al. Nat Rev Endocrinol. 2018 Jul;14(7):390-403. doi: 10.1038/s41574-018-0016-2. Nat Rev Endocrinol. 2018. PMID: 29728598 Review.

5

Future Perspectives on GLP-1 Receptor Agonists and GLP-1/glucagon Receptor Co-agonists in the Treatment of NAFLD.

Seghieri M, Christensen AS, Andersen A, Solini A, Knop FK, Vilsbøll T. Seghieri M, et al. Among authors: andersen a. Front Endocrinol (Lausanne). 2018 Nov 6;9:649. doi: 10.3389/fendo.2018.00649. eCollection 2018. Front Endocrinol (Lausanne). 2018. PMID: 30459715 Free PMC article. Review.

6

[Biomarkers of cardiovascular disease in patients with Type 2 diabetes].

Krogh SK, Andersen A, Knop FK, Vilsbøll T. Krogh SK, et al. Among authors: andersen a. Ugeskr Laeger. 2019 Feb 18;181(8):V10180711. Ugeskr Laeger. 2019. PMID: 30821245 Free article. Danish.

7

[Glucagon-like peptide 1 receptor agonists for the treatment of Type 2 diabetes].

Andersen A, Christensen AS, Knop FK, Vilsbøll T. Andersen A, et al. Ugeskr Laeger. 2019 Mar 18;181(12):V10180725. Ugeskr Laeger. 2019. PMID: 30931886 Free article. Review. Danish.

8

Hypoglycaemia and cardiac arrhythmias in diabetes.

Andersen A, Jørgensen PG, Knop FK, Vilsbøll T. Andersen A, et al. Ther Adv Endocrinol Metab. 2020 May 19;11:2042018820911803. doi: 10.1177/2042018820911803. eCollection 2020. Ther Adv Endocrinol Metab. 2020. PMID: 32489579 Free PMC article. Review.

9

Comparison of the injection-site experience of the starting doses with semaglutide and dulaglutide: A randomized, double-blind trial in healthy subjects.

Snitker S, Andersen A, Berg B, van Marle S, Sparre T. Snitker S, et al. Among authors: andersen a. Diabetes Obes Metab. 2021 Jun;23(6):1415-1419. doi: 10.1111/dom.14349. Epub 2021 Mar 18. Diabetes Obes Metab. 2021. PMID: 33591618 Free PMC article. Clinical Trial.

10

Duration of type 2 diabetes does not appear to moderate hypoglycaemia rate with insulin degludec versus insulin glargine U100.

Alexopoulos AS, Andersen A, Donatsky AM, Gowda A, Buse JB. Alexopoulos AS, et al. Among authors: andersen a. Diabetes Obes Metab. 2021 Aug;23(8):1983-1988. doi: 10.1111/dom.14397. Epub 2021 May 6. Diabetes Obes Metab. 2021. PMID: 33830626 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,522 results

Search Page

Filters